Analyst Ratings for Marker Therapeutics (MRKR)
MRKR Rating Summary
MRKR Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$7.80 (+465.2%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 89%
Rating Score: 9 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2025 | Canaccord | John Newman | New Coverage | Buy (N/A) |
8.00 (N/A) |
1.38 (1.38) |
0% | Details |
| 2/11/2025 | Brookline Capital Markets » Updated 1/5/2026 |
Leah Rush Cann | New Coverage | Buy (N/A) |
5.60 (4.00) |
1.77 (1.38) |
-22.03% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


